HRP20110655T1 - 2-amino-7,8-dihidro-6h-pirido(4,3-d)pirimidin-5-oni, postupak njihove proizvodnje i farmaceutski sastavi koji ih sadrže - Google Patents

2-amino-7,8-dihidro-6h-pirido(4,3-d)pirimidin-5-oni, postupak njihove proizvodnje i farmaceutski sastavi koji ih sadrže Download PDF

Info

Publication number
HRP20110655T1
HRP20110655T1 HR20110655T HRP20110655T HRP20110655T1 HR P20110655 T1 HRP20110655 T1 HR P20110655T1 HR 20110655 T HR20110655 T HR 20110655T HR P20110655 T HRP20110655 T HR P20110655T HR P20110655 T1 HRP20110655 T1 HR P20110655T1
Authority
HR
Croatia
Prior art keywords
amino
phenyl
pyrimidin
methyl
fluoro
Prior art date
Application number
HR20110655T
Other languages
English (en)
Croatian (hr)
Inventor
D. Machajewski Timothy
M. Shafer Cynthia
Mcbride Christopher
Antonios-Mccrea William
M. Doughan Brandon
H. Levine Barry
Xia Yi
Mckenna Maureen
Michael Wang X.
Mendenhall Kris
Zhou Yasheen
Gong Baoqing
Gu Dan
Dolan John
Tulinsky John
Brinner Kristin
Gao Zhenhai
A. Renhowe Paul
Poon Daniel
A. Barsanti Paul
Lin Xiaodong
Pick Teresa
Costales Abran
Brammeier Nathan
Rico Alice
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HRP20110655T1 publication Critical patent/HRP20110655T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
HR20110655T 2005-09-30 2011-09-13 2-amino-7,8-dihidro-6h-pirido(4,3-d)pirimidin-5-oni, postupak njihove proizvodnje i farmaceutski sastavi koji ih sadrže HRP20110655T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72279605P 2005-09-30 2005-09-30
US83688606P 2006-08-09 2006-08-09
PCT/US2006/038181 WO2007041362A1 (en) 2005-09-30 2006-09-28 2-amino-7,8-dihydro-6h-pyrido[4,3-d] pyrimidin-5-ones

Publications (1)

Publication Number Publication Date
HRP20110655T1 true HRP20110655T1 (hr) 2011-10-31

Family

ID=37661234

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110655T HRP20110655T1 (hr) 2005-09-30 2011-09-13 2-amino-7,8-dihidro-6h-pirido(4,3-d)pirimidin-5-oni, postupak njihove proizvodnje i farmaceutski sastavi koji ih sadrže

Country Status (32)

Country Link
US (2) US7671059B2 (es)
EP (1) EP1928875B1 (es)
JP (2) JP5036002B2 (es)
KR (1) KR101311757B1 (es)
AR (1) AR058072A1 (es)
AT (1) ATE514694T1 (es)
AU (1) AU2006297124B2 (es)
BR (1) BRPI0616701A2 (es)
CA (1) CA2624253C (es)
CR (1) CR9846A (es)
CY (1) CY1112028T1 (es)
DK (1) DK1928875T3 (es)
EA (1) EA016152B1 (es)
EC (1) ECSP088324A (es)
GE (1) GEP20115231B (es)
HK (1) HK1118823A1 (es)
HR (1) HRP20110655T1 (es)
IL (1) IL190446A0 (es)
JO (1) JO2783B1 (es)
MA (1) MA29885B1 (es)
ME (1) ME01952B (es)
MY (1) MY143604A (es)
NO (1) NO342258B1 (es)
NZ (1) NZ566914A (es)
PE (1) PE20070621A1 (es)
PL (1) PL1928875T3 (es)
PT (1) PT1928875E (es)
RS (1) RS51795B (es)
SM (1) SMAP200800029A (es)
TN (1) TNSN08143A1 (es)
TW (1) TWI373471B (es)
WO (1) WO2007041362A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2007002994A1 (es) * 2006-10-19 2008-02-08 Wyeth Corp Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros.
CN101225083A (zh) * 2007-01-16 2008-07-23 北京摩力克科技有限公司 四氢喹唑啉酮类化合物及其用于制备治疗和预防病毒性疾病的药物的用途
GB2449293A (en) * 2007-05-17 2008-11-19 Evotec Compounds having Hsp90 inhibitory activity
ES2475206T3 (es) * 2008-02-01 2014-07-10 Takeda Pharmaceutical Company Limited Derivados de oxima como inhibidores de HSP90
CA2737948A1 (en) 2008-09-26 2010-04-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Host cell kinases as targets for antiviral therapies against hcv infection
KR101749353B1 (ko) * 2008-11-28 2017-06-20 노파르티스 아게 Hsp90 억제제 및 mtor 억제제를 포함하는 제약 조합물
AU2009319051A1 (en) * 2008-11-28 2010-06-03 Novartis Ag Hsp90 inhibitors for therapeutic treatment
KR20110103980A (ko) * 2008-11-28 2011-09-21 노파르티스 아게 피리도〔4,3-d〕피리미딘 유래의 hsp90-억제제 및 her2 억제제를 포함하는 제약 조합물
AR075180A1 (es) * 2009-01-29 2011-03-16 Novartis Ag Formulaciones orales solidas de una pirido-pirimidinona
AR077405A1 (es) 2009-07-10 2011-08-24 Sanofi Aventis Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer
FR2949467B1 (fr) 2009-09-03 2011-11-25 Sanofi Aventis Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation
BR112012010085B1 (pt) * 2009-10-29 2020-02-04 Genosco composto, quantidade terapeuticamente eficaz de um composto, formulação farmacêutica
WO2012104823A2 (en) 2011-02-04 2012-08-09 Novartis Ag Pyridopyrimidinone compounds in the treatment of neurodegenerative diseases
JP6180420B2 (ja) 2011-10-14 2017-08-16 ノバルティス アーゲー 増殖性疾患の治療のためのhsp90阻害剤と組み合わせた2−カルボキサミドシクロアミノウレア誘導体
ITTO20111013A1 (it) 2011-11-03 2013-05-04 Dac Srl Composti farmaceutici
CN103664938A (zh) * 2012-09-12 2014-03-26 山东亨利医药科技有限责任公司 含有嘧啶并环的syk抑制剂
BR112015010396A2 (pt) 2012-11-07 2017-07-11 Novartis Ag terapia de combinação
US9677907B2 (en) * 2013-03-14 2017-06-13 Itron Inc Intelligent receptacle
GB201306610D0 (en) * 2013-04-11 2013-05-29 Almac Discovery Ltd Pharmaceutical compounds
PL3053578T3 (pl) * 2013-09-30 2021-06-14 Taiho Pharmaceutical Co., Ltd. Skojarzona terapia przeciwnowotworowa z zastosowaniem związku azabicyklicznego
RU2690853C2 (ru) * 2014-09-02 2019-06-06 Пьер Фабр Медикамент Производные изохинолинона, полезные для лечения рака
KR20160035411A (ko) * 2014-09-23 2016-03-31 주식회사 오스코텍 LRRK2 (Leucine Rich Repeat Kinase 2) 키나제 억제제로서의 피리도피리미딘 유도체 화합물
KR101653560B1 (ko) * 2016-02-02 2016-09-12 한국화학연구원 신규한 화합물 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 함유하는 인플루엔자 바이러스 감염으로 인한 질환의 예방 또는 치료용 약학적 조성물
RU2629599C1 (ru) * 2016-09-28 2017-08-30 Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" (ГБУЗ МО МОНИКИ им. М.Ф. Владимирского) Способ химиолучевого лечения опухолей прямой кишки и анального канала
CN115916752A (zh) * 2020-06-26 2023-04-04 日本农药株式会社 芳基四氢吡啶衍生物或其盐类、和含有该化合物的杀虫剂及其使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6165873A (ja) * 1984-09-07 1986-04-04 Mitsui Petrochem Ind Ltd 2−ピペラジノピリミジン誘導体
CA1307786C (en) 1984-12-14 1992-09-22 Keiichi Yokoyama Quinazoline derivatives and antihypertensive preparations containing same as effective components
MA21177A1 (fr) 1987-02-11 1988-10-01 May & Baker Ltd Diones cycliques.
ATE305303T1 (de) * 2001-02-12 2005-10-15 Hoffmann La Roche 6-substituierte pyridopyrimidine
DE102004018198A1 (de) 2004-04-15 2005-11-03 Merck Patent Gmbh Sulfonamide
WO2006045096A2 (en) 2004-10-20 2006-04-27 Resverlogix Corp. Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
WO2006074293A2 (en) 2005-01-07 2006-07-13 President And Fellows Of Harvard College Bicyclic dihydropyrimidines as eg5 inhibitors
TW200718689A (en) 2005-04-14 2007-05-16 Chiron Corp 2-Amino-quinazolin-5-ones

Also Published As

Publication number Publication date
US20100004237A1 (en) 2010-01-07
KR101311757B1 (ko) 2013-09-26
EP1928875A1 (en) 2008-06-11
JP2009510108A (ja) 2009-03-12
US7671059B2 (en) 2010-03-02
PE20070621A1 (es) 2007-09-06
IL190446A0 (en) 2008-11-03
CA2624253C (en) 2015-06-16
JO2783B1 (en) 2014-03-15
WO2007041362A1 (en) 2007-04-12
EA016152B1 (ru) 2012-02-28
CR9846A (es) 2008-08-01
AR058072A1 (es) 2008-01-23
HK1118823A1 (es) 2009-02-20
GEP20115231B (en) 2011-06-10
NO342258B1 (no) 2018-04-30
RS51795B (en) 2011-12-31
NZ566914A (en) 2011-09-30
SMP200800029B (it) 2008-05-07
BRPI0616701A2 (pt) 2011-06-28
MA29885B1 (fr) 2008-10-03
ECSP088324A (es) 2008-04-28
SMAP200800029A (it) 2008-05-07
TWI373471B (en) 2012-10-01
TW200728304A (en) 2007-08-01
CY1112028T1 (el) 2015-11-04
NO20082069L (no) 2008-06-09
US20070123546A1 (en) 2007-05-31
AU2006297124B2 (en) 2011-12-08
PT1928875E (pt) 2011-09-06
ATE514694T1 (de) 2011-07-15
AU2006297124A1 (en) 2007-04-12
MY143604A (en) 2011-06-15
TNSN08143A1 (en) 2009-07-14
JP2012158611A (ja) 2012-08-23
KR20080057318A (ko) 2008-06-24
CA2624253A1 (en) 2007-04-12
PL1928875T3 (pl) 2011-11-30
EP1928875B1 (en) 2011-06-29
ME01952B (en) 2011-12-31
EA200800992A1 (ru) 2008-10-30
JP5036002B2 (ja) 2012-09-26
DK1928875T3 (da) 2011-10-03

Similar Documents

Publication Publication Date Title
HRP20110655T1 (hr) 2-amino-7,8-dihidro-6h-pirido(4,3-d)pirimidin-5-oni, postupak njihove proizvodnje i farmaceutski sastavi koji ih sadrže
ES2916220T3 (es) Inhibidores del receptor de factor de crecimiento de fibroblasto
JP2009510108A5 (es)
CA2687180C (en) Novel amide derivative for inhibiting the growth of cancer cells
ES2924915T3 (es) Inhibidores de RHO cinasa
ES2779152T3 (es) Derivados de (2-(5-isoindolin-2-il)pirimidin-4-il)-amina como inhibidores de Rho-quinasa para tratar enfermedades autoinmunes
JP2008536867A5 (es)
Abdellatif et al. Pyrimidine and fused pyrimidine derivatives as promising protein kinase inhibitors for cancer treatment
RU2019120986A (ru) Фармацевтическая комбинация, содержащая ингибитор alk и ингибитор shp2
AU2010286569B2 (en) Compounds and compositions as protein kinase inhibitors
ES2893580T3 (es) Inhibidores de miristato de moléculas pequeñas de Bcr-abl y métodos de uso
US20080182870A1 (en) PYRIDO(3,2-d)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS
CN106535890A (zh) 5‑取代的吲唑‑3‑羧酰胺及其制备和应用
RU2007110950A (ru) Пиримидиновые производные
JP2016522232A5 (es)
AU2016382515A1 (en) Acrylanilide derivative, preparation method therefor, and applications thereof in pharmacy
RU2006121337A (ru) Производные пиразола и их применение в качестве ингибиторов рецепторных тирозинкиназ
HRP20120762T1 (hr) Tetrasupstituirani piridazini kao inhibitori hedgehog puta
AU2010291318A1 (en) Novel pyrimidine and triazine hepcidine antagonists
Yerragunta et al. Pyrimidine and its biological activity: a review
KR20150104089A (ko) 치환된 인돌-5-올 유도체와 그들의 치료적 용도
ES2895749T3 (es) Métodos de tratamiento del cáncer pancreático
CN104350049B (zh) 作为激酶抑制剂的取代氨基喹唑啉
JP2016514717A5 (es)
JP2016522231A5 (es)